Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | DOI: 10.5507/bp.2024.025

Dysfibrinogenemia and hypofibrinogenemia - Spectrum of pathogenic variants in Slovak patients

Dominika Jaraskovaa, Jan Chandogaa, Angelika Batorovab, Tatiana Prigancovab, Miriama Juhosovaa, Pavol Durinaa, Alzbeta Vavrovaa, Silvia Dallemulea, Robert Petrovica, Anna Kyselovab, Denisa Jankovicovab, Daniel Bohmera
a Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University, Slovakia
b National Haemophilia Centre, Department of Haematology, Faculty of Medicine, Comenius University and University Hospital Bratislava, Slovakia

Introduction: Congenital hypofibrinogenemia (CH) and congenital dysfibrinogenemia (CD) are rare coagulation disorders caused by quantitative or qualitative defects in the fibrinogen gene. The aim of this study was to characterize the genetic background and the clinical manifestations of congenital fibrinogen disorders in the patients from Slovakia registered at the National Haemophilia Centre.

Materials and Methods: Results of genetic analysis of the fibrinogen genes FGA, FGB and FGG using polymerase chain reaction followed by direct sequencing were evaluated in 36 patients.

Results: Molecular-genetic analysis revealed six novel variants - FGA c.923_968dup p.(Gly324Lysfs*44) and FGG c.1105C>T p.(His369Tyr) were identified in CD patients. In CH patients, in the FGG gene c.8G>A p.(Trp3*), c.823G>T p.(Glu275*) and c.323C>A p.(Ala108Asp) variants were detected. In the FGB gene c.1427C>T p.(Ser476Leu) was identified.

Conclusion: This study is a positive contribution towards expanding knowledge about genetic variants in patients with congenital fibrinogen disorders.

Keywords: dysfibrinogenemia, hypofibrinogenemia, FGA, FGB, FGG

Received: January 21, 2024; Revised: June 18, 2024; Accepted: July 15, 2024; Prepublished online: July 29, 2024 

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Huang S, Mulvihill ER, Farrell DH, Chung DW, Davie EW. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in the assembly. J Biol Chem 1993;268(12):8919-26. doi: 10.1016/S0021-9258(18)52960-4 Go to original source...
    2. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3(8):1894-904. doi: 10.1111/j.1538-7836.2005.01365.x Go to original source... Go to PubMed...
    3. de Maat MP, Verschuur M. Fibrinogen heterogeneity: inherited and noninherited. Curr Opin Hematol 2005;12(5):377-83. doi: 10.1097/01.moh.0000169287.51594.3b Go to original source... Go to PubMed...
    4. Human fibrinogen database presentation, Groupe Français d'étude sur l'Hémostase et la Thrombose. Available from: https://site.geht.org/base-fibrinogene/, 2021 (accessed 1 April 2021).
    5. Maghzal GJ, Brennan SO, Homer VM, George PM. The molecular mechanisms of congenital hypofibrinogenaemia. Cell Mol Life Sci 2004;61:1427-38. doi: 10.1007/s00018-004-3458-8 Go to original source... Go to PubMed...
    6. Casini A, Undas A, Palla R, Thachil J, de Moerloose P. Subcommittee on Factor XIII and Fibrinogen, Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH. J Thromb Haemost 2018;16(9):1887-90. doi: 10.1111/jth.14216 Go to original source... Go to PubMed...
    7. Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, Gautier P, Biron C, Neerman-Arbez M, de Moerloose P. Natural history of patients with congenital dysfibrinogenemia. Blood 2015;125(3):553-61. doi: 10.1182/blood-2014-06-582866 Go to original source... Go to PubMed...
    8. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995;73(1):151-61. doi: 10.1055/s-0038-1653741 Go to original source...
    9. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci 2001;936:89-90. doi: 10.1111/j.1749-6632.2001.tb03495.x Go to original source... Go to PubMed...
    10. Bátorová A, Jankovičová D, Lazúr J, Prigancová T, de Moerloose P, Neerman-Arbez M, Kušíková M, Mistrík M. Vrodená dysfibrinogenémia a hypofibrinogenémia - molekulová báza a klinický fenotyp. Interná Med 2016;16(3):109-15. (In Slovak)
    11. Vu D, de Moerloose P, Batorova A, Lazur J, Palumbo L, Neerman-Arbez M. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion. J Med Genet 2005;42(9):e57. doi: 10.1136/jmg.2005.033530 Go to original source... Go to PubMed...
    12. Bátorová A, Horváthová D, de Moerloose P, Neerman-Arbez M, Mistrík M. Fenotypová a genotypová analýza vrodenej hypofibrinogenémie a dysfibrinogenémie. Vnitř Lék 2005;51(7-8):802-8. (In Slovak)
    13. Batorova A, Horvathova D, Mistrik M, de Moerloose P, Neerman-Arbez M. Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-Fibrinogenemia. Fibrinogen Bratislava. Blood 2005;106(11):1794. doi: 10.1182/blood.V106.11.1794.1794 Go to original source...
    14. Kotlín R, Reicheltová Z, Malý M, Suttnar J, Sobotková A, Salaj P, Hirmerová J, Riedel T, Dyr JE. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzeň. Thromb Haemost 2009;102(3):479-86. doi: 10.1160/TH08-11-0771 Go to original source... Go to PubMed...
    15. Simurda T, Zolkova J, Kolkova Z, Loderer D, Dobrotova M, Skornova I, Brunclíkova M, Grendar M, Lasabova Z, Stasko J, Kubisz P. Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia. Int J Hematol 2020;111(6):795-802. doi: 10.1007/s12185-020-02842-9 Go to original source... Go to PubMed...
    16. Wypasek E, Klusowska A, Zdziarska J, Zawilska K, Treliński J, Iwaniec T, Mital A, Pietrys D, Sydor W, Neerman-Arbez M, Undas A. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations. Thromb Res 2019;182:133-40. doi: 10.1016/j.thromres.2019.08.012 Go to original source... Go to PubMed...
    17. Ceznerova E, Stikarova J, Roselova P, Kaufmanova J, Suttnar J, Louzil J, Kotlin R, Salaj P, Dyr JE. Molecular and Clinical Aspects of Aα Dysfibrinogenemia in 25 Patients from the Czech Republic. Blood 2018;132(Supplement 1):5046. doi: 10.1182/blood-2018-99-118254 Go to original source...
    18. Simurda T, Caccia S, Asselta R, Zolkova J, Stasko J, Skornova I, Snahnicanova Z, Loderer D, Lasabova Z, Kubisz. Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop). J Thromb Thrombolysis 2020;50(1):233-6. doi: 10.1007/s11239-019-01991-x Go to original source... Go to PubMed...
    19. Shapiro SE. Diagnosis and management of dysfibrinogenemia. Clin Adv Hematol Oncol 2018;16(9):602-5.
    20. Casini A, Neerman-Arbez M, de Moerloose P. Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management. Blood Rev 2020;26;100793. doi: 10.1016/j.blre.2020.100793 Go to original source... Go to PubMed...
    21. Shapiro SE, Phillips E, Manning RA, Morse CV, Murden SL, Laffan MA, Mumford AD. Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia. Br J Haematol 2013;160(2):220-7. doi: 10.1111/bjh.12085 Go to original source... Go to PubMed...
    22. Casini A, de Moerloose P, Neerman-Arbez M. Clinical Features and Management of Congenital Fibrinogen Deficiencies. Semin Thromb Hemost 2016;42(4):366-74. doi: 10.1055/s-0036-1571339 Go to original source... Go to PubMed...
    23. Peyvandi F, Haertel S, Knaub S, Mannucci PM. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost 2006;4(7):1634-7. doi: 10.1111/j.1538-7836.2006.02014.x Go to original source... Go to PubMed...
    24. Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J, Lu Y, Wu X, Liang Q, Wang H, Wang X. Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia. Blood Cells, Molecules and Diseases 2015;55(4):308-15. doi: 10.1016/j.bcmd.2015.06.002 Go to original source... Go to PubMed...
    25. Mosesson MW, Siebenlist KR, DiOrio JP, Matsuda M, Hainfeld JF, Wall JS. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg->Cys). J Clin Invest 1995;96(2):1053-8. doi: 10.1172/JCI11809126 Shimizu A, Nagel GM, Doolittle RF. Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to gamma-chain residues 337-379. Proc Natl Acad Sci U S A 1992;89(7):2888-92. doi: 10.1073/pnas.89.7.2888 Go to original source...
    26. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at position A alpha 312 and B beta 448. Blood 1993;82:2117-24. doi: 10.1182/blood.V82.7.2117.2117 Go to original source...
    27. Standeven KF, Grant PJ, Carter AM, Schneider T, Weisel JW, Ariëns RAS. Functional 29Analysis of the Fibrinogen Aα Thr312Ala Polymorphism. Effects on Fibrin Structure and Function. Circulation 2003;107:2326-30. doi: 10.1161/01.CIR.0000066690.89407.CE Go to original source... Go to PubMed...
    28. Ajjan R, Lim BCB, Standeven KF, Harrand R, Dolling S, Phoenix F, Greaves R, Abou-Saleh RH, Connell S, Smith DAM, Weisel JW, Grant PJ, Ariëns RAS. Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity. Blood 2008;111(2):643-50. doi: 10.1182/blood-2007-05-091231 Go to original source... Go to PubMed...
    29. Simurda T, Zolkova J, Snahnicanova Z, Loderer D, Skornova I, Sokol J, Hudecek J, Stasko J, Lasabova Z, Kubisz P. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders. Int J Mol Sci 2018;19(1):100. doi: 10.3390/ijms19010100 Go to original source... Go to PubMed...
    30. Casini A, Vilar R, Beauverd Y, Aslan D, Devreese K, Mondelaers V, Alberio L, Gubert C, de Moerloose P, Neerman-Arbez M. Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia. Haemophilia 2017;23(4):583-9. doi: 10.1111/hae.13190 Go to original source... Go to PubMed...
    31. Neerman-Arbez M, de Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations. Hum Mutat 2007;28(6):540-53. doi: 10.1002/humu.20483 Go to original source... Go to PubMed...
    32. Amri Y, Dabboubi R, Mghaieth F, Zili M, Messaoud T, Casini A, de Moerloose P, Toumi NEH. Molecular characterization of two hypofibrinogenemic patients associated with a novel FGG IVS6+23T>A substitution and a previously reported FGB IVS6-10_16delTTTG deletion. Haemophilia 2020;26(4):e194-7. doi: 10.1111/hae.13974 Go to original source... Go to PubMed...
    33. Terasawa F, Kamijyo Y, Fujihara N, Yamauchi K, Kumagai T, Honda T, Shigematsu S, Okumura N. In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A>G causing abnormal RNA splicing. Clin Chim Acta 2010;411(17-18):1325-9. doi: 10.1016/j.cca.2010.05.030 Go to original source... Go to PubMed...
    34. Brennan SO, Fellowes AP, Faed JM, George PM. Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations. Blood 2000;95(5):1709-13. doi: 10.1182/blood.V95.5.1709.005k04_1709_1713 Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return